These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23090072)

  • 21. Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy.
    Williams MD; Suliburk JW; Staerkel GA; Busaidy NL; Clayman GL; Evans DB; Perrier ND
    Ann Surg Oncol; 2009 Nov; 16(11):3146-53. PubMed ID: 19727961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
    Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
    Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second tumors in pediatric patients treated with radiotherapy to the central nervous system.
    Galloway TJ; Indelicato DJ; Amdur RJ; Swanson EL; Smith AA; Marcus RB
    Am J Clin Oncol; 2012 Jun; 35(3):279-83. PubMed ID: 21383606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hurthle cell neoplasm of the thyroid gland.
    Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F
    ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment.
    Chow SM; Yau S; Lee SH; Leung WM; Law SC
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):992-1000. PubMed ID: 15234032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
    Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
    J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid cancer in infants and adolescents after Chernobyl.
    Reiners C; Demidchik YE; Drozd VM; Biko J
    Minerva Endocrinol; 2008 Dec; 33(4):381-95. PubMed ID: 18923372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid adenomas and carcinomas following radiotherapy for a hemangioma during infancy.
    Haddy N; Andriamboavonjy T; Paoletti C; Dondon MG; Mousannif A; Shamsaldin A; Doyon F; Labbé M; Robert C; Avril MF; Fragu P; Eschwege F; Chavaudra J; Schvartz C; Lefkopoulos D; Schlumberger M; Diallo I; de Vathaire F
    Radiother Oncol; 2009 Nov; 93(2):377-82. PubMed ID: 19515442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
    Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
    Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fine needle aspiration biopsy of the thyroid gland in patients with prior Graves' disease treated with radioactive iodine. Morphologic findings and potential pitfalls.
    Centeno BA; Szyfelbein WM; Daniels GH; Vickery AL
    Acta Cytol; 1996; 40(6):1189-97. PubMed ID: 8960027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of Second Primary Cancer Risk After Treatment with Radioactive Iodine for Differentiated Thyroid Carcinoma.
    Corrêa NL; de Sá LV; de Mello RC
    Thyroid; 2017 Feb; 27(2):261-270. PubMed ID: 27762670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.
    Marti JL; Jain KS; Morris LG
    Thyroid; 2015 Jun; 25(6):681-7. PubMed ID: 25851829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasound screening for thyroid carcinoma in childhood cancer survivors: a case series.
    Brignardello E; Corrias A; Isolato G; Palestini N; Cordero di Montezemolo L; Fagioli F; Boccuzzi G
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4840-3. PubMed ID: 18812481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of Nonthyroidal Primary Malignancy and the Association with (131)I Treatment in Patients with Differentiated Thyroid Cancer.
    Hirsch D; Shohat T; Gorshtein A; Robenshtok E; Shimon I; Benbassat C
    Thyroid; 2016 Aug; 26(8):1110-6. PubMed ID: 27302111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasound surveillance for thyroid malignancies in survivors of childhood cancer following radiotherapy: a single institutional experience.
    Li Z; Franklin J; Zelcer S; Sexton T; Husein M
    Thyroid; 2014 Dec; 24(12):1796-805. PubMed ID: 25286003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is radioactive iodine- 131 treatment related to the occurrence of non-synchronous second primary malignancy in patients with differentiated thyroid cancer?
    Souza MC; Momesso DP; Vaisman F; Vieira Neto L; Martins RA; Corbo R; Vaisman M
    Arch Endocrinol Metab; 2016 Feb; 60(1):9-15. PubMed ID: 26222230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The risk of second primary malignancy is increased in differentiated thyroid cancer patients with a cumulative (131)I dose over 37 GBq.
    Khang AR; Cho SW; Choi HS; Ahn HY; Yoo WS; Kim KW; Kang KW; Yi KH; Park DJ; Lee DS; Chung JK; Cho BY; Park YJ
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):117-23. PubMed ID: 25115234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid nodules after high-dose external radiotherapy. Fine-needle aspiration cytology in diagnosis and management.
    Pretorius HT; Katikineni M; Kinsella TJ; Barsky SH; Brennan MF; Chu EW; Robbins J
    JAMA; 1982 Jun; 247(23):3217-20. PubMed ID: 7087060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of papillary thyroid cancer.
    Vassilopoulou-Sellin R
    Oncology (Williston Park); 1995 Feb; 9(2):145-51; discussion 151-2, 154, 157. PubMed ID: 8771097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer?
    Campennì A; Giovanella L; Siracusa M; Stipo ME; Alibrandi A; Cucinotta M; Ruggeri RM; Baldari S
    Thyroid; 2014 Nov; 24(11):1607-11. PubMed ID: 25089829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.